Antisense modulation of phospholipid scramblase i expresion

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/04 (2006.01) C12N 15/11 (2006.01) C12N 15/85 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2443641

Antisense compounds, compositions and methods are provided for modulating the expression of Phospholipid scramblase I. The compositions comprise antisense compounds, particularly antisense olignonucleotides, targeted to nucleic acids encoding Phospholipid scramblase I expression and for treatment of diseases associated with expression of Phospholipid scramblase I are provided.

L'invention porte sur des composés antisens, sur des compositions et sur des procédés visant à moduler l'expression de la scramblase I phospholipidique. Les compositions comprennent des composés antisens, notamment des olignonucléotides antisens, ciblés sur les acides nucléiques codant l'expression de la scramblase I phospholipidique. L'invention porte également sur des procédés d'utilisation de ces composés dans la modulation de l'expression de la scramblase I phospholipidique et dans le traitement de maladies associées à l'expression de la scramblase I phospholipidique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense modulation of phospholipid scramblase i expresion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of phospholipid scramblase i expresion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of phospholipid scramblase i expresion will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1681079

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.